| Literature DB >> 25356675 |
Timothy D Witchell1, Azad Eshghi1, Jarlath E Nally2, Rebecca Hof1, Martin J Boulanger1, Elsio A Wunder3, Albert I Ko3, David A Haake4, Caroline E Cameron1.
Abstract
BACKGROUND: Leptospirosis, a re-emerging disease of global importance caused by pathogenic Leptospira spp., is considered the world's most widespread zoonotic disease. Rats serve as asymptomatic carriers of pathogenic Leptospira and are critical for disease spread. In such reservoir hosts, leptospires colonize the kidney, are shed in the urine, persist in fresh water and gain access to a new mammalian host through breaches in the skin. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2014 PMID: 25356675 PMCID: PMC4214626 DOI: 10.1371/journal.pntd.0003280
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
LipL32 synthetic peptides generated for immune recognition studies.
| Peptide | Amino Acid Sequence | Modification |
| P1 |
| none |
| P1-K152Me3 |
| tri-methylation on K152 |
| P2 |
| none |
| P2-K178Me3 |
| tri-methylation on K178 |
Figure 1Two-dimensional gel electrophoresis (2DGE) of Leptospira whole proteome profiles indicating LipL32 protein spots analyzed by MS/MS.
(A) 2DGE profile of in vitro-cultured Leptospira (IVCL) and (B) 2DGE profile of rat urine-isolated Leptospira (RUIL). Protein derived from whole cells were separated using immobilized pH gradient IPG strips (pH 3–10, non-linear) followed by SDS-PAGE. Circled protein spots corresponding to LipL32 were excised for analysis by LC-MS/MS.
Identity and confirmed post-translational modification status of detected LipL32 peptides.
| Sample | Peptide sequence | Modification | Location | |||
| IVCL | RUIL | |||||
| 1 | 2 | 1 | 2 | |||
| - | - | √ | √ |
| acetylation or tri-methylation | K29 |
| - | - | √ | - |
| tri-methylation | K152 |
| - | - | - | √ |
| acetylation or tri-methylation | K166 |
| - | - | √ | - |
| acetylation or tri-methylation | K172 |
| - | - | √ | √ |
| acetylation or tri-methylation (RUIL1) or tri-methylation | K178 |
| - | - | √ | √ |
| acetylation or tri-methylation | K199 |
| - | - | √ | √ |
| acetylation or tri-methylation | K245 |
| - | - | - | √ |
| tri-methylation | K246 |
| √ | √ | √ | √ |
| - | - |
| √ | √ | √ | √ |
| - | - |
| - | √ | √ | √ |
| - | - |
| √ | - | √ | - |
| - | - |
| √ | √ | √ | √ |
| - | - |
| - | - | √ | √ |
| - | - |
| - | √ | - | √ |
| - | - |
| √ | √ | √ | √ |
| - | - |
| √ | √ | √ | √ |
| - | - |
| √ | √ | √ | √ |
| - | - |
| √ | √ | √ | √ |
| - | - |
Peptides detected within in vitro-cultured Leptospira (IVCL) and rat urine-isolated Leptospira (RUIL) 2DGE samples are listed.
*modified lysine residues are indicated by underlined bold font.
**confirmed tri-methylation indicated by the presence of the M+-59 neutral loss ion.
***refers to the amino acid residue containing the modified lysine residue. The identified amino acid residue corresponds to the location within the mature LipL32 protein sequence.
Figure 2Leptospirosis patient serum reactivity against modified and unmodified versions of synthetic LipL32 peptides.
Shown is the reactivity of pooled sera from laboratory-confirmed leptospirosis patients (black bars) and LipL32-specific polyclonal rabbit serum (white bars) to unmodified and tri-methylated (KMe3) versions of P1 and P2 peptides comprising experimentally-determined B-cell epitopes of LipL32 [36]. Two independent experiments were performed with reproducible results; the results from one representative experiment are shown. Error bars represent standard error of measurement from triplicate samples. For statistical analyses, the level of reactivity of patient sera against the unmodified version of P1 was compared to the level of reactivity against the P1 peptide containing a tri-methylation at position K152 (P1-K152Me3) using the Student's two-tailed t-test (*p<0.0001).
Figure 3Modified lysine residues mapped onto the Ca2+ bound LipL32 structure [39].
A. Secondary structure and B. surface representations. The numbering system C1-K253 corresponds to the mature LipL32 protein (lacking the 19 residue cleaved SPII signal sequence) established by Vivian et al. [40] and adopted by Tung et al. [39]. Note, the Ca2+ binding site and predicted collagen binding surface in panel B are highlighted in yellow and frame Lys199. The figure was generated using PyMOL (Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC).